Healthcare - Biotechnology - NASDAQ - DE
$ 2.54
-4.87 %
$ 570 M
Market Cap
-1.97
P/E
BALANCE SHEET
788 M
ASSETS
271 M
LIABILITIES
517 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
CureVac N.V.
| Current Assets | 478 M |
| Cash & Short-Term Investments | 403 M |
| Receivables | 17.1 M |
| Other Current Assets | 58.5 M |
| Non-Current Assets | 310 M |
| Long-Term Investments | 15.9 M |
| PP&E | 279 M |
| Other Non-Current Assets | 15.3 M |
| Current Liabilities | 186 M |
| Accounts Payable | 46.4 M |
| Short-Term Debt | 5 M |
| Other Current Liabilities | 135 M |
| Non-Current Liabilities | 84.9 M |
| Long-Term Debt | 36.8 M |
| Other Non-Current Liabilities | 48.1 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 402.8 | 495.8 | 811.5 | 1 322.6 | 30.7 | 21.4 |
| Short Term Investments | 0 | 4.5 | 4.6 | 2.6 | 1.5 | 39.3 |
| Receivables | 17.1 | 9.0 | 53.7 | 1.8 | 17.2 | 6.9 |
| Inventory | 24.8 | 24.0 | 56.2 | 14.5 | 6.2 | 3.0 |
| Other Current Assets | 9.0 | 20.3 | 14.0 | 48.3 | 1.7 | 2.6 |
| Total Current Assets | 478.4 | 584.0 | 940.0 | 1 389.9 | 57.2 | 73.1 |
| PP&E | 278.6 | 241.7 | 200.4 | 104.8 | 66.8 | 45.5 |
| Intangible Assets | 15.9 | 19.3 | 13.2 | 14.1 | 5.7 | 6.2 |
| Goodwill | 12.5 | 12.5 | 0 | 0 | 0 | 0 |
| Long Term Investments | 15.9 | 0 | 0.5 | 1.0 | 0 | 0.7 |
| Other Long Term Assets | (13.0) | 1.7 | 1.2 | 1.1 | 1.0 | 1 K |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 788.2 | 860.5 | 1 158.2 | 1 511.4 | 130.6 | 125.7 |
| LIABILITIES | ||||||
| Accounts Payable | 46.4 | 68.2 | 122.3 | 17.6 | 5.3 | 9.0 |
| Short Term Debt | 5.0 | 5.0 | 3.5 | 3.2 | 2.0 | 0 |
| Other Current Liabilities | 88.0 | 44.7 | 171.4 | 56.1 | 13.2 | 13.1 |
| Total Current Liabilities | 186.4 | 156.2 | 357.7 | 247.6 | 28.1 | 28.1 |
| Long Term Debt | 36.8 | 37.1 | 25.4 | 26.9 | 77.1 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 1.6 | 0 |
| Other Liabilities | 0 | 133.9 | 86.6 | 25.5 | 68.2 | 0.9 |
| Total Liabilities | 271.3 | 327.2 | 469.8 | 800.0 | 173.4 | 93.6 |
| EQUITY | ||||||
| Common Stock | 26.9 | 23.4 | 22.5 | 21.7 | 0.7 | 0.7 |
| Retained Earnings | (1 566.0) | (1 305.8) | (1 056.8) | (645.1) | (515.9) | (416.1) |
| Other Accumulative Comprehensive Income/Loss | 2 056.0 | 1 817.1 | 1 728.6 | 1 334.8 | 472.4 | 447.4 |
| Total Equity | 516.9 | 533.3 | 688.5 | 711.3 | (42.8) | 32.1 |
| Total Liabilities and Equity | 788.2 | 860.5 | 1 158.2 | 1 511.4 | 130.6 | 125.7 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 220.5 | 189.1 | 186.0 | 132.2 | 186.9 | 176.0 |